The G-217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population

被引:19
作者
Wu, SJ
Chiang, FT
Jiang, JR
Hsu, KL
Chern, TH
Tseng, YZ
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei, Taiwan
[3] Chang Gung Mem Hosp, Ctr Trad Chinese Med, Dept Internal Med 2, Taipei 10591, Taiwan
关键词
angiotensinogen; polymorphisms; hypertension; gene regulation; Taiwanese; case-control study; transfection;
D O I
10.1097/00004872-200311000-00015
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective Polymorphisms of the angiotensinogen (AGT) gene, especially in the promoter region, are in linkage concordance and are associated with hypertension. In this study, we examined the role of AGT promoter polymorphisms, including G-217A, A-6G and M235T variants, and their promoter function in essential hypertension in Taiwanese populations. Design An association study was conducted to assess the genotype distribution between hypertensive patients and normotensive subjects. We also used a transient transfection assay to examine basal transcriptional activity of G-217A and A-6G variants in a mammalian cell system. Methods Hypertensive subjects (390) and normotensive controls (388) of Taiwanese ethnicity were genotyped for the AGT G-217A, A-6G and M235T variants. Promoter activity was studied by cloning the promoter region (-614 to +41 bp) of AGT into the pSEAP2-Basic reporter vector and performing a transient transfection assay in HuH7 and HepG2 cells. Results The G-217A variant of the AGT gene was significantly associated with hypertension (P = 0.0047), but the A-6G and M235T polymorphisms were not (P = 0.17 and P = 0.33, respectively). Furthermore, the recessive model of homozygous genotype (-217AA) conferred a high risk for hypertension (odds ratio 3.64) in this population. The -217A variant expressed higher transcriptional activity than -217G in vitro. Conclusions Our study showed a significant association between the -217A variant of the AGT gene and hypertension. This variant plays a functional role in basal transcription of AGT, and may confer a risk for hypertension in Taiwanese populations. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:2061 / 2067
页数:7
相关论文
共 35 条
[1]   Evaluation of the angiotensinogen locus in human essential hypertension - A European study [J].
Brand, E ;
Chatelain, N ;
Keavney, B ;
Caulfield, M ;
Citterio, L ;
Connell, J ;
Grobbee, D ;
Schmidt, S ;
Schunkert, H ;
Schuster, H ;
Sharma, AM ;
Soubrier, F .
HYPERTENSION, 1998, 31 (03) :725-729
[2]  
Brasier AR, 1999, VITAM HORM, V57, P217
[3]   Mechanisms for inducible control of angiotensinogen gene transcription [J].
Brasier, AR ;
Li, JY .
HYPERTENSION, 1996, 27 (03) :465-475
[4]   LINKAGE OF THE ANGIOTENSINOGEN GENE LOCUS TO HUMAN ESSENTIAL-HYPERTENSION IN AFRICAN CARIBBEAN [J].
CAULFIELD, M ;
LAVENDER, P ;
NEWELLPRICE, J ;
FARRALL, M ;
KAMDAR, S ;
DANIEL, H ;
LAWSON, M ;
DEFREITAS, P ;
FOGARTY, P ;
CLARK, AJL .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :687-692
[5]   Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese [J].
Chiang, FT ;
Hsu, KL ;
Tseng, CD ;
Hsiao, WH ;
Lo, HM ;
Chern, TH ;
Tseng, YZ .
JOURNAL OF HYPERTENSION, 1997, 15 (06) :607-611
[6]   Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse [J].
Cvetkovic, B ;
Keen, HL ;
Zhang, XJ ;
Davis, D ;
Yang, BL ;
Sigmund, CD .
PHYSIOLOGICAL GENOMICS, 2002, 11 (03) :253-262
[7]   Hypertension genetics, single nucleotide polymorphisms, and the common disease: Common variant hypothesis [J].
Doris, PA .
HYPERTENSION, 2002, 39 (02) :323-331
[8]   STRUCTURE OF HUMAN ANGIOTENSINOGEN GENE [J].
GAILLARD, I ;
CLAUSER, E ;
CORVOL, P .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1989, 8 (02) :87-99
[9]   KINETICS OF HUMAN RENIN AND HUMAN SUBSTRATE REACTION [J].
GOULD, AB ;
GREEN, D .
CARDIOVASCULAR RESEARCH, 1971, 5 (01) :86-&
[10]   Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension - Trials of hypertension prevention, phase II [J].
Hunt, SC ;
Cook, NR ;
Oberman, A ;
Cutler, JA ;
Hennekens, CH ;
Allender, PS ;
Walker, WG ;
Whelton, PK ;
Williams, RR .
HYPERTENSION, 1998, 32 (03) :393-401